To Compare the Efficacy of Kalmegh Vati versus Amlodipine in Stage 1 Hypertension

Evaluation of Comparative Efficacy of Kalmegh Vati versus Amlodipine in the Management of Stage 1 Essential Hypertension A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/12/060794

Enrollment

Registered

2023-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients, willing to participate with written informed consent. 2.Age between 30-60 years of either sex. Subjects having Systolic blood pressure 140-159mmHg & Diastolic blood pressure between 90- 99mmHg (Stage-1 hypertension as per JNC 8 guidelines).

Exclusion criteria

Exclusion criteria: 1.Cases of major illness like cardiovascular disorders like cardiogenic shock, unstable angina, aortic stenosis, diabetes mellitus and renal disorders. 2.Patients taking medication like glucocorticoids. 3.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Reduction in systolic and diastolic blood pressure, pulse pressure.Timepoint: 30 Days	—

Secondary

Measure	Time frame
Reduction in BMITimepoint: 30 Days	—

Countries

India

Contacts

Public ContactDr Sadhana Misar Wajpeyi

Datta Meghe Institute Of Higher Education and Research

sadhanamisar@gmail.com9763732083

Outcome results